期刊文献+

人前列腺癌细胞中肝X受体特异性激动剂GW3965对核受体结合蛋白1的影响 被引量:1

Effect of GW3965 on NRBP1 expression in prostate cancer cells
下载PDF
导出
摘要 目的探讨人前列腺癌细胞系DU145细胞中肝X受体(liver X receptor,LXR)特异性激动剂GW3965对核受体结合蛋白1(nuclear receptor binding protein 1,NRBP1)的表达调控作用。方法采用MTT法检测不同浓度GW3965(浓度分别为0.5、5、10μmol/L)作用24 h后对DU145细胞增殖的影响。在人前列腺癌DU145细胞中用LXR的特异性激动剂GW3965处理24 h后,经逆转录-聚合酶链反应(RT-PCR)检测LXR特异性靶基因三磷腺苷结合A1(ATP-bindingcassette A1,ABCA1)转录水平的表达情况;随后在转录水平和翻译水平检测NRBP1的表达。结果 LXR特异性激动剂GW3965各实验组对细胞的活性和增殖无影响(P>0.05)。GW3965作用于DU145细胞后,ABCA1转录水平呈剂量依赖性升高,表明LXR在DU145细胞中具有功能活性。LXR经过活化后在转录和翻译水平对NRBP1的抑制作用呈剂量依赖性降低。结论 LXR在DU145细胞中可抑制NRBP1的表达。 Objective To investigate the effect of liver X receptor(LXR) specific agonist GW3965 on the expression of nuclear receptor binding protein 1 (NRBPI) in DU145 cell line of prostate cancer. Methods The effect of various GW3965 concentrations (0.5,5,10 μmol/L) on the proliferation of DU145 cells was detected by the MTF test. DU 145 cells were treated with GW3965 for 24 h and then ATP-binding cassette A 1 (ABCA 1 ) mRNA was detected by RT-PCR;NRBP1 mRNA and protein were assayed by using RT-PCR and Western blot. Results GW3965 had no effect on the activity and proliferation of DU145 cells (P〉0.05). The level of ABCA 1 mRNA was close-dependently increased, after treating DU 145 cells with different concentrations of GW3965 for 24 h respectively, which demonstrated that LXR had the functional activity in DU145. NRBP1 were down- regulated in both mRNA and protein level after LXR activation. Conclusion LXR could inhibit the expression of NRBP1 in DU145 cells.
出处 《现代医药卫生》 2012年第17期2561-2563,共3页 Journal of Modern Medicine & Health
基金 国家自然科学基金资助项目(30901593)
关键词 前列腺肿瘤 细胞 受体 细胞表面 激动剂 受体 胞质和核 GW3965 核受体结合蛋白1 Prostatic neoplasms Cells Liver Receptors,cell surface/agonists Receptors,cytoplasmic and nu-c|e^r: GW3965 Nuclear receptor binding protein 1
  • 相关文献

参考文献9

  • 1Chua JJ,Ng MM,Chow VT,et al. The non-structural 3(NS3) protein of dengue virus type 2 interacts with human nuclear receptor binding protein and is associated with alterations in membrane structure [J]. Virus Res, 2004,102(2) : 151-163.
  • 2Lin J, Yang R,Tarr PT, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-lbeta coactivation of SREBP[J]. Cell,2005, 120(2) :261-273.
  • 3Jakobsson T, Venteclef N, Toresson G, et al. GPS2 is required for choles- terol efflux by triggering histone demethylation,LXR recruitment,and coregulator assembly at the ABCG1 locus [J]. Mol Ce11,2009,34 (4):510- 518.
  • 4Kim GH, Park K, Yeom SY, et al. Characterization of ASC-2 as an antia- therogenic transcriptional coactivator of liver X receptors in macrophages[J]. Mol Endoerinol, 2009,23 (7) : 966-974.
  • 5Ruiz C, Oeggerli M ,Germann M ,et al. High NRBP1 expression in pro- state cancer is linked with poor clinical outcomes and increased cancer cell growth[J/OL]. Prostate ,201212012-04-02]. http ://www.ncbi.nlm.nih. gov/pubmed.
  • 6Gluderer S, Brunner E, Germann M, et al. Madm (Mlfl adapter molecule) cooperates with Bunched A to promote growth in Drosophila[J]. J Biol, 2010,9(1):9.
  • 7Wang H, Sun X, Luo Y, et al. Adapter protein NRBP associates with Jabl and negatively regulates AP - 1 activity [J]. FEBS Lett, 2006,580 (25) : 6015-6021.
  • 8Hooper JD, Baker E, Ogboume SM, et al. Cloning of the cDNA and local- ization of the gene encoding human NRBP,a ubiquitously expressed, multidomain putative adapter protein[J]. Genomics, 2000,66 ( 1 ) : 113-118.
  • 9De Langhe S, Haataja L,Senadheera D, et al. Interaction of the small GTPase Rat3 with NRBP, a protein with a kinase-homology domain[J]. Int J Mol Med ,2002,9(5) :451-459.

同被引文献39

  • 1Fukuchi J,Kokontis JM, Hiipakka RA, et at. Antiproliferativeeffect of liver X receptor agonists on LNCaP human prostate cancer cells[J]. Cancer Res,2004,64(21) :7686-7689.
  • 2Chuu CP, Lin HP. Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines[J]. Anticancer Res, 2010,30 (9) : 3643-3648.
  • 3Chuu CP. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer[J]. Med Hypotheses, 2011,76(5) :697-699.
  • 4Chuu CP, Kokontis JM, Hiipakka RA, et al. Modulation of liver X receptor signaling as novel therapy for prostate cancer [J]. J Biomed Sci,2007,14(5) :543-553.
  • 5Faulds MH, Zhao C, Dahlman-Wright K. Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases[J]. Curt Opin Pharmacol, 2010,10(6) :692-697.
  • 6Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR[J]. Nat Rev Mol Cell Biol,2012,13(4) :213-224.
  • 7Korach-Andr6 M, Gustafsson JA. Liver X receptors as regulators of metabolism[J]. Biomol Concepts, 2015,6 (3) : 177-190.
  • 8Hayashi T, Kotani H, Yamaguchi T, et al. Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes[J]. Proc Natl Acad Sci U S A,2014,111(3):1168-1173. 4.
  • 9Vedin LL, Lewandowski SA, Parini P, et al. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells[J]. Carcinogenesis, 2009,30 (4) : 575-579.
  • 10York AG, Bensinger SJ. Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth[J]. J Exp Med,2013,210(9) :1653-1656.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部